The largest database of trusted experimental protocols

4 protocols using preceiver m02

1

UCP1 Promoter Activity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After cloning and amplifying the UCP1 promoter region, the PCR products were cloned into the multiple cloning sites of pGL4.10. HEK-293T cells were co-transfected with pGL4.10-UCP1-prom- oter, PGL4.74 (Promega) and pReceiver-M02 (Genecopoeia) using Lipo3000 Transfection Reagent (Thermo Fisher Scientific, USA). After 48 h, cells were lysed, 100 μL of the cell lysate was added to each well, and the cells were incubated on a shaker at room temperature (24–26 °C) for 15 min. The cell lysate (20 μL) was added to 100 μL of luciferase assay reagent II (LARII) automatically by the machine. Next, 100 μL of Renilla luciferase assay reagent was added to the mixture to determine Renilla luciferase activity. The ratio of firefly luciferase and TK Renilla luciferase activity represented the reporter gene activity value. TK Renilla luminescence value was used as an internal reference. The experiment was performed in triplicate and expressed as the mean ± SD.
+ Open protocol
+ Expand
2

Heterologous expression of hTRPV3 in HEK293T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human TRPV3 (pReceiver-M02) was purchased from Gene-Copoeia (Rockville, MD, USA) and subcloned into pcDNA 3.1 (Thermo Fisher). One day before transfection, HEK293T cells are subseeded onto a 35-mm diameter cell culture dish at 60% confluence. The following day, the cells were transfected with Lipofectamine Plus reagent (Thermo Fisher) according to the manufacturer's instructions. In all the transfection studies, we cotransfected pEGFP-N1 plasmid, which can express a green fluorescence protein, with hTRPV3 plasmid to allow for selecting transfected cells based on the green fluorescence signal. pEGFP-N1 was cotransfected into HEK293T cells at a ratio of 9 (hTRPV3):1 (EGFP).
+ Open protocol
+ Expand
3

Generating Mutant TRPV3 Channels in HEK 293T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids carrying TRPV3 (pReceiver-M02), TRPV4 (pReceiver-M29), and TRPA1 (pReceiver-M29) were bought from Genecopoeia (Rockville, MD, USA). Using the Quick Change II XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA), mutant TRPV3 channels were generated using the PCR-based site-directed mutagenesis method. The forward and reverse primers for the G573S mutant were 5′-GGGGTTTCCAGTCCATGAGCATGTACAGCGTCATG-3′ and 5′-CATGACGCTGTACATGCTCATGGACTGGAAACCCC-3′, respectively. The forward and reverse primers for the G573C mutant were 5′-GGGGTTTCCAGTCCATGTGCATGTACAGCGTCATG-3′ and 5′-CATGACGCTGTACATGCACATGGACTGGAAACCCC-3′, respectively. Sequencing was used to confirm mutagenesis.
TRPV3 (WT and mutants), TRPV4, and TRPA1 plasmids were transiently transfected into HEK 293T cells, as previously described [45 (link),46 (link)]. pEGFP (pEGFP-N1, Life Technologies) was co-transfected with the plasmid carrying TRPV3 WT or the TRPV3 mutants into HEK 293T cells to identify transfected cells. Turbofect reagent (Thermo Fisher Scientific, Waltham, MA, USA) was used for transfection. All experiments were performed after a further 24–36 h incubation after transfection.
+ Open protocol
+ Expand
4

Mammary Gland-Derived Cell Line Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four human mammary gland-derived cell lines (MCF-10A, MCF-12A, MDA-MB-231, and MCF-7) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). MCF-10A and MCF-12A were cultured in MEGM (Lonza, Basel, Switzerland) with 100 ng/ml cholera toxin. MDA-MB-231 and MCF-7 were cultured in RPMI1640 (Gibco, Grand Island, NY, USA) supplemented with 10% FBS and 1% penicillin and streptomycin. A KLHDC7B-expressing plasmid vector harboring full-length cDNA in pReceiver-M02 was purchased from Genecopoeia (Rockville, MD, USA; Cat. No.: EX-T2688-M02). For STAR1-expressing vector, a DNA fragment spanning the cDNA (GenBank No.: NR_034129.1) was chemically synthesized (Genecopoeia) and subcloned into the pcDNA 3.1/Hygro(+) (Invitrogen, Carlsbad, CA, USA). The siRNAs of KLHDC7B and STAR1 were designed by Bioneer (Daejeon, South Korea) and Qiagen (Redwood City, CA, USA), respectively. Plasmid vectors and siRNAs were transfected with Lipofectamine 3000 and lipofectamin RNAIMAX (Invitrogen) following the supplier instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!